Medigene AG (VIE:MDG2)

Market Cap	821.80K -95.7%
Revenue (ttm)	7.45M -17.5%
Net Income	-15.93M
EPS	-1.26
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	104
Open	0.0342
Previous Close	0.0342
Day's Range	0.0342 - 0.0342
52-Week Range	0.0342 - 2.0300
Beta	n/a
RSI	27.69
Earnings Date	n/a

About Medigene AG

Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1994
• Employees: 87
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: MDG2

Financial Performance

In 2023, Medigene AG's revenue was 6.03 million, a decrease of -80.69% compared to the previous year's 31.25 million. Losses were -16.18 million, 94.2% more than in 2022.